Swiss National Bank Rocket Pharmaceuticals, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 124,600 shares of RCKT stock, worth $1.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

124,600

Previous 124,600 -0.0%

Holding current value

$1.76 Million

Previous $2.68 Million 14.21%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$26.16 - $30.74 $219,744 - $258,216	-8,400 Reduced 6.32%	124,600 $3.36 Million
Q4 2023 Feb 06, 2024	BUY	$16.78 - $31.94 $154,376 - $293,848	9,200 Added 7.43%	133,000 $3.99 Million
Q3 2023 Nov 08, 2023	BUY	$15.07 - $24.05 $43,703 - $69,745	2,900 Added 2.4%	123,800 $2.54 Million
Q2 2023 Aug 09, 2023	SELL	$16.59 - $23.6 $107,835 - $153,400	-6,500 Reduced 5.1%	120,900 $2.4 Million
Q1 2023 May 10, 2023	SELL	$15.79 - $22.6 $72,634 - $103,960	-4,600 Reduced 3.48%	127,400 $2.18 Million
Q4 2022 Feb 08, 2023	BUY	$15.5 - $22.76 $472,750 - $694,180	30,500 Added 30.05%	132,000 $2.58 Million
Q3 2022 Nov 09, 2022	BUY	$12.37 - $18.41 $34,636 - $51,548	2,800 Added 2.84%	101,500 $1.62 Million
Q2 2022 Aug 09, 2022	BUY	$7.96 - $16.64 $58,108 - $121,472	7,300 Added 7.99%	98,700 $1.36 Million
Q1 2022 May 09, 2022	BUY	$13.16 - $23.68 $96,068 - $172,864	7,300 Added 8.68%	91,400 $1.45 Million
Q3 2021 Nov 08, 2021	BUY	$27.42 - $48.97 $109,680 - $195,880	4,000 Added 4.99%	84,100 $2.51 Million
Q2 2021 Aug 06, 2021	BUY	$39.41 - $47.25 $421,686 - $505,575	10,700 Added 15.42%	80,100 $3.55 Million
Q1 2021 May 07, 2021	BUY	$43.34 - $65.91 $26,004 - $39,546	600 Added 0.87%	69,400 $3.08 Million
Q3 2020 Nov 09, 2020	BUY	$20.5 - $28.59 $32,800 - $45,744	1,600 Added 2.38%	68,800 $1.57 Million
Q2 2020 Aug 05, 2020	BUY	$13.32 - $22.61 $49,284 - $83,657	3,700 Added 5.83%	67,200 $1.41 Million
Q1 2020 May 08, 2020	BUY	$9.71 - $25.11 $8,739 - $22,599	900 Added 1.44%	63,500 $886,000
Q4 2019 Feb 06, 2020	BUY	$11.07 - $24.23 $65,313 - $142,957	5,900 Added 10.41%	62,600 $1.43 Million
Q3 2019 Nov 12, 2019	BUY	$10.85 - $14.78 $20,615 - $28,082	1,900 Added 3.47%	56,700 $661,000
Q2 2019 Aug 02, 2019	BUY	$15.0 - $19.81 $154,500 - $204,043	10,300 Added 23.15%	54,800 $822,000
Q1 2019 May 10, 2019	BUY	$13.45 - $19.01 $91,460 - $129,268	6,800 Added 18.04%	44,500 $781,000
Q2 2018 Aug 09, 2018	BUY	$14.58 - $23.0 $549,666 - $867,100	37,700 New	37,700 $740,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.07B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Rocket Pharmaceuticals, Inc. Transaction History